07:00 , Aug 1, 2016 |  BioCentury  |  Emerging Company Profile

Faster than McDonald

IQuity Inc. is developing assays to diagnose autoimmune diseases as soon as symptoms appear based on differences in RNA expression of both coding and non-coding genes. The company's first test could help physicians confirm difficult...
07:00 , May 30, 2016 |  BC Week In Review  |  Company News

Theranostics Health, Avant Diagnostics deal

Avant acquired fellow diagnostic company Theranostics Health for 25 million shares of Avant valued at $8 million based on Avant’s close of $0.32 on May 11, the day before the deal was announced. Theranostics markets...
07:00 , May 30, 2016 |  BC Week In Review  |  Company News

Amarantus BioScience, Avant Diagnostics deal

Avant acquired Amarantus BioScience’s Amarantus Diagnostics Inc. subsidiary for 80 million shares of Avant stock valued at $25.6 million based on Avant’s close of $0.32 on May 11, the day before the deal closed. Amarantus...